NTLA

NASDAQStock

Intellia Therapeutics, Inc.

$12.79-0.23 (-1.77%)

52-Week Range

$6.28

$27.98

Key Stats

Market Cap

1.5B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.02

Volume

2.6M

Avg Volume

4.6M

Performance

+7.08%

+40.59%

+11.06%

YTD

+39.52%

+39.37%

-67.98%

-81.12%

Price Chart

ETF Exposure

NTLA is held by 78 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
DCOR	Dimensional - US Core Equity 1 ETF	0.01%	17,433	$235K	$2.68B	0.14%
HDG	ProShares - Hedge Replication ETF	0.01%	115	$2K	$23.2M	0.95%
ONEQ	FIDELITY NASDAQ COMPOSITE INDEX ETF	0.01%	40,215	$542K	$9.01B	0.21%
DFAU	Dimensional - US Core Equity Market ETF	0.00%	26,998	$364K	$10.55B	0.12%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	152,104	$2.0M	$81.53B	0.03%
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.00%	3,060	$40K	$1.43B	0.09%
AVUS	Avantis U.S. Equity ETF	0.00%	13,957	$188K	$11.08B	0.15%
DFUS	Dimensional - US Equity Market ETF	0.00%	27,543	$371K	$18.80B	0.09%
IWV	iShares Russell 3000 ETF	0.00%	23,403	$315K	$17.58B	0.20%
SCHB	Schwab U.S. Broad Market ETF	0.00%	68,091	$917K	$38.14B	0.03%
VTHR	Vanguard Russell 3000 ETF	0.00%	8,319	$109K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	3,640,982	$47.9M	$2.10T	0.03%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	56	$750	$64.1M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	66	$889	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	55	$740	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	36	$488	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	27	$369	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	12	$164	$9.5M	0.12%
AVTM	Avantis Total Equity Markets ETF 1	0.00%	17	$228	$694.1M	0.23%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	9	$116	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	28	$383	$81.5M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	48	$652	$81.7M	0.11%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	2,801	$35K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	2,801	$35K	$6.3M	0.60%
TILT	FlexShares Morningstar U.S. Market Factor Tilt Index Fund	0.00%	306	$4K	$1.90B	0.26%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	2,801	$35K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	2,801	$35K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	2,801	$35K	$3.7M	0.70%

PreviousPage 2 of 2

About NTLA ETF Exposure

Intellia Therapeutics, Inc. (NTLA) is held by 78 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.5B, NTLA is a widely held institutional stock. The stock currently trades at $12.79. Investors can gain exposure to NTLA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NTLA, sorted by portfolio weight.